1. Home
  2. NNNN vs TRS Comparison

NNNN vs TRS Comparison

Compare NNNN & TRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

HOLD

Current Price

$25.50

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Logo TriMas Corporation

TRS

TriMas Corporation

HOLD

Current Price

$42.97

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
NNNN
TRS
Founded
2021
1986
Country
Germany
United States
Employees
27
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Industrial Specialties
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.3B
IPO Year
N/A
2004

Fundamental Metrics

Financial Performance
Metric
NNNN
TRS
Price
$25.50
$42.97
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$41.50
AVG Volume (30 Days)
12.8K
391.9K
Earning Date
04-07-2026
04-30-2026
Dividend Yield
N/A
0.44%
EPS Growth
N/A
400.00
EPS
N/A
21.40
Revenue
N/A
$645,720,000.00
Revenue This Year
N/A
$5.42
Revenue Next Year
N/A
$4.27
P/E Ratio
$446.57
$1.96
Revenue Growth
N/A
N/A
52 Week Low
$7.03
$24.56
52 Week High
$55.65
$42.48

Technical Indicators

Market Signals
Indicator
NNNN
TRS
Relative Strength Index (RSI) 49.55 72.69
Support Level $26.31 $33.53
Resistance Level $30.21 N/A
Average True Range (ATR) 2.10 1.63
MACD -0.28 0.59
Stochastic Oscillator 20.78 92.17

Price Performance

Historical Comparison
NNNN
TRS

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).

About TRS TriMas Corporation

TriMas Corp designs, develops and manufactures a diverse set of products for the consumer products, and industrial markets . The company operates through two segments namely: The packaging segment manufactures and distributes closure and dispensing systems. The specialty product segment manufactures and distributes steel cylinders, wellhead engines, compression systems, industrial sealing, and fasteners. The packaging segment generates majority of its revenue.

Share on Social Networks: